Furthermore, our findings strongly suggest that targeting the rate-limiting steps in collagen secretion, such as HTRA1-mediated trafficking, can effectively alleviate DCM-associated myocardial fibrosis and improve cardiac function. The gene discussed is HTRA1; the disease is familial dilated cardiomyopathy.